Brief communications 625 epidemic of necrotic enteritis with symptoms identical to those described here. However, recent changes in management, including stress reduction, the addition of roughage to the diet, exposure to adult gastrointestinal microflora, and the replacement of the sulfamerazine with oral penicillin, have reduced the mortality by approximately 50%. Permanent institution of these measures (prior to clinical signs) could prevent or greatly reduce mortality in future outbreaks. Clostridium difficile enterotoxemia may be a common problem in captive ostrich chicks, and the utilization of early diagnosis by selective culture, biochemical identification, and ELISA enterotoxin assay may limit the potential for severe mortality.
Bacterial septicemia and airsacculitis in ducks are major disease problems, resulting in substantial economic losses due to high mortality and condemnations. 14 The causative agents of septicemia and airsacculitis include Salmonella spp., Escherichia coli, staphylococci, and Pasteurella SPP. 4, 13, 14 Antimicrobial therapy is an important tool in reducing both the incidence and mortality associated with these diseases. 4, 13, 14 Although a variety of antimicrobials have been used to treat septicemia and airsacculitis in poultry, a paucity of infor-From Animal Health Discovery Research, The Upjohn Company, Kalamazoo, MI 49001 (Watts, Salmon, Yancey) , and Maple Leaf Farms, Milford, IN 46542 (Nersessian, Kounev) .
Received for publication November 3, 1992. mation exists on the minimum inhibitory concentrations (MICs) of organisms isolated from septicemia and airsacculitis in ducks. 14 Ceftiofur is an extended-spectrum cephalosporin with good activity against the gram-negative enteric pathogens and moderate activity against Staphylococcus aureus. 15 Ceftiofur has been approved for use in the treatment of bovine respiratory disease since 1988 and has been recently approved for swine respiratory disease and early chick mortality. However, no data are available on the activity of ceftiofur against bacteria isolated from septicemia and airsacculitis in ducks. The purpose of this study was to determine the MICs of bacteria isolated from septicemia and airsacculitis in ducks for ceftiofur and 7 comparator antimicrobials. A total of 187 isolates were used in the study. All isolates were obtained from cases of septicemia and airsacculitis in White Pekin ducks (Anas anas platyrhinchos) at a commercial duck production facility. Bacteria were isolated on trypticase blood agar base a supplemented with 5% sheep blood and were transported to The Upjohn Company (Kalamazoo, MI) for final identification and MIC determinations. Upon receipt at the laboratory, all isolates were checked for purity and stored in 1 ml of trypticase soy broth a supplemented with 10% glycerin on 3-mm glass beads at -70 C until revived. Isolates were subcultured twice on blood agar prior to testing.
Each isolate was identified presumptively based upon col-ony morphology, hemolytic pattern, and organoleptic characteristics. Initial groupings were confirmed by Gram's stain and catalase, tube coagulase, and oxidase tests. Gram-negative isolates were identified using conventional and commercially available identification systems. b Staphylococci and streptococci were identified using commercial identification systems. c Differentiation of Staphylococcus intermedius from S. aureus was confirmed on the basis of mannitol and maltose utilization as previously described. 6 MIC determinations were conducted using a commercial dehydrated 96-well MIC panel and a semiautomated inoculation system. d Inoculation and MIC determinations were performed as per the manufacturer's instructions. The fol- lowing antimicrobials were tested: ceftiofur (XNL), ampicillin (AMP), erythromycin (E), tetracycline (TE), enrofloxacin (ENR), spectinomycin (SPC), sulfamethazine (SMZ), and trimethoprim/sulfadiazine (TBR). Dilution ranges for the antimicrobials were as follows: XNL, AMP, E, TE, ENR, 0.03-32.0 µg/ml; SPC, 0.13-128.0 µg/ml; SMZ, 10-512.0 µg/ml; and TBR, 0.015/0.3-16.0/304.0 µg/ml. The following quality control organisms were included in the study: S. aureus ATCC 29213, E. coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Enterococcus faecalis ATCC 29212. 9 The quality control ranges specified by the manufacturer for the various antimicrobials were used in the study.
Of the 187 isolates tested, 150 (80.2%) were gram-negative bacilli (Table 1) , with the majority identified as E. coli (105). Eighteen strains were identified as Salmonella spp.; serotyping revealed that 8 of these strains were S. enteritidis, 6 were S. agona, 2 were S. johannesburg, and 1 each were S. tennessee and S. typhimurium. Two organisms were identified as Vibrio cholerae by 2 commercial identification systems. Toxin analysis confirmed that the strains were nontoxigenic V. cholerae. Eighteen strains were identified as Proteus mirabilis, 2 strains as Acinetobacter lwoffi, 1 strain as an Aeromonas spp., and 1 strain as Pseudomonas aeruginosa. Thirty-seven gram-positive cocci were isolated ( Previous studies on the antimicrobial susceptibility of bacteria isolated from ducks categorized those isolates as susceptible or resistant based upon interpretive criteria devel-oped for human isolates. 2, 8, 9, 11, 12 However, the extrapolation of interpretive criteria based upon the pharmacokinetics of humans or another domestic species to another species is not valid. Because valid interpretive criteria based upon the pharmacokinetics of the tested antimicrobials in ducks are not available, the isolates could not be categorized as resistant or susceptible and only the MIC data are reported.
Typical of other extended-spectrum cephalosporins, ceftiofur exhibited good activity against the enteric bacilli (MIC,, ≤ 1.0 µg/ml) and moderate to good activity against the staphylococci (MIC 90 ≤ 2.0 µg/ml). However, 5 strains of E. coli and 1 strain of Proteus mirabilis demonstrated MICs ≥ 16.0 µg/ml to ceftiofur. Ceftiofur was not active against the single Pseudomonas aeruginosa strain tested. This finding agrees with that of a previous study, which indicated that ceftiofur was not active against P. aeruginosa. 15 Currently, ceftiofur is not approved for use in ducks, and the pharmacokinetic information necessary for establishing MIC breakpoints is not available for this host species.
The fluoroquinolones are a new class of antimicrobials that exhibit excellent activity against gram-negative bacilli, moderate to good activity against staphylococci, and fair to poor activity against streptococci and strict anaerobes. 1 Enroflox-,acin was included in the present study as a representative of the fluoroquinolone group of antimicrobials. Enrofloxacin exhibited good activity (MIC 90 ≤ 0.5 g/ml) against both the gram-negative bacilli and the staphylococci isolated from cases of septicemia and airsacculitis in ducks. However, use of this group of compounds in poultry may be inappropriate because of cross-resistance with fluoroquinolones used for treatment of human enteric infections. 3, 10 None of the remaining antimicrobials exhibited the broadspectrum in vitro activity demonstrated by ceftiofur and enrofloxacin. Ampicillin exhibited acceptable activity against Staphylococcus intermedius (MIC 90 = 0.13 µg/ml) and Salmonella spp. (MIC 90 = 2.0 µg/ml). Erythromycin, tetracycline, spectinomycin, and sulfamethazine were relatively inactive against the gram-negative bacilli and the staphylococci. Trimethoprim/sulfadiazine demonstrated good activity (MIC 90 ≤ 1.0 g/ml) against E. coli, Salmonella spp., Proteus mirabilis, and Staphylococcus aureus.
Of the 28 staphylococcal isolates, 14 were identified as S. intermedius. Staphylococcus intermedius was originally isolated from pigeons and carnivores, particularly dogs. 5 It is a hemolytic, nonpigmented, coagulase-positive, crystal violet type E Staphylococcus species that utilizes mannitol but not maltose aerobically. 5 Although S. intermedius has not been previously reported as isolated from ducks, Kusch characterized 380 staphylococci isolated from poultry (including ducks) and determined that 26 (6.8%) were crystal violet type E. 7 The S. intermedius strains encountered in the present study had much higher MIC values for trimethoprim/sulfadiazine than did the S. aureus strains.
Ceftiofur and enrofloxacin were the compounds that exhibited the broadest spectrum of activity against bacteria isolated from septicemia and airsacculitis in ducks. Because strains of E. coli and Proteus mirabilis exhibiting high MICs for ceftiofur were encountered and reports of use of fluoroquinolones in poultry may cause cross-resistance with human enteric pathogens, prudent use of these compounds in avian species is highly recommended. Results of the present study represent isolates from 1 production facility. Additional studies are needed to determine the prevalence and antimicrobial resistance in the other duck production facilities.
